Cargando…
Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism
BACKGROUND: Cancer cachexia is a metabolic disorder involving perturbed energy balance and altered mitochondrial function. Chemotherapy is a primary treatment option for many types of cancer, but there is substantial evidence that some chemotherapeutic agents can also lead to the development and pro...
Autores principales: | Pin, Fabrizio, Barreto, Rafael, Couch, Marion E., Bonetto, Andrea, O'Connell, Thomas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438345/ https://www.ncbi.nlm.nih.gov/pubmed/30680954 http://dx.doi.org/10.1002/jcsm.12360 |
Ejemplares similares
-
Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia
por: O’Connell, Thomas M., et al.
Publicado: (2019) -
Metabolic Biomarkers for the Early Detection of Cancer Cachexia
por: O’Connell, Thomas M., et al.
Publicado: (2021) -
Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia
por: Ballarò, Riccardo, et al.
Publicado: (2021) -
ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass
por: Barreto, Rafael, et al.
Publicado: (2017) -
Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition
por: Pin, Fabrizio, et al.
Publicado: (2018)